Professional Documents
Culture Documents
Secondary metabolites (SMs) are generally defined as small organic molecules produced by
an organism that are not essential for their growth, development and reproduction.
From: Biotechnology and Biology of Trichoderma, 2014
Related terms:
Abstract
Microbial secondary metabolites are low-molecular-mass products of secondary metabolism,
usually produced during the late growth phase (idiophase) of microorganisms. They have
unusual structures and their production arises from intracellular intermediates (amino acids,
sugars, fatty acids, etc.), which are condensed into more complex structures by defined
biochemical pathways. They are not essential for the growth of the producing cultures, but
serve diverse survival functions in nature. They are very important for the human health and
economics of our society. They include antibiotics, antitumor agents, cholesterol-lowering
drugs, immunosuppressants, antihelmintic agents and other antiparasitics, herbicides,
ruminant growth stimulators, agricultural fungicides, bio-insecticides, and others. The most
important secondary metabolites have been the anti-infective drugs and, among these, the β-
lactams are the most important class. Other important classes include the aminoglycosides,
tetracyclines, macrolides, lipopeptides, polyenes, and the echinocandins. Successful microbial
secondary metabolites include many used to combat cancer, such as the anthracycline
doxorubicin and bleomycin. Antitumor agents from plants that have been very useful are
taxol and camptothecin. If modern medicine is to continue in its present form, novel families
of antibiotics and other secondary metabolites must continue to be discovered and enter the
marketplace at regular intervals.
View chapter
Explore book
1.12.1 Introduction
Of all the traditional products made by fermentation, the most important to human health
are the secondary metabolites (idiolites). These are metabolites which (1) are often produced
in a developmental phase of batch culture (idiophase) subsequent to growth, (2) have no
function in growth, (3) are produced by narrow taxonomic groups of organisms, (4) have
unusual and varied chemical structures, and (5) are often formed as mixtures of closely
related members of a chemical family. In nature, their functions serve the survival of the
strain, but when the producing microorganisms are grown in pure culture, the secondary
metabolites have no such role. Thus, production ability in industry is easily lost by mutation
(‘strain degeneration’). In batch or fed-batch culture, secondary metabolites are produced
usually after growth has slowed down. Their formation is regulated by nutrients, growth rate,
feedback control, enzyme inactivation, and induction. Secondary metabolism is mainly
carried out by plants and microorganisms and is usually strain specific. Secondary
metabolites appear to serve the organisms that produce them as (1) competitive weapons
used against other microorganisms, plants, insects, and large animals; (2) metal transporting
agents; (3) agents of plant–microbe symbiosis and plant growth stimulation; (4) sexual
hormones; and (5) differentiation effectors.
Secondary metabolites have a major effect on the health, nutrition, and economics of our
society. The best known are the antibiotics. This remarkable group of compounds forms a
heterogeneous assemblage of biologically active molecules with different structures and
modes of action. They attack virtually every type of microbial activity such as DNA, RNA, and
protein synthesis, membrane function, electron transport, sporulation, germination, and
many others. Other secondary metabolites are pesticides, pigments, toxins, effectors of
ecological competition and symbiosis, pheromones, enzyme inhibitors, immunomodulating
agents, receptor antagonists and agonists, pesticides, antitumor agents, immunosuppressives,
cholesterol-lowering agents, plant protectants, and growth promotants of animals and plants.
As a result, they have tremendous economic importance. More than 10 000 antibiotics have
been discovered. Most are useless; they are either too toxic or inactive in living organisms to
be used.
Idiolites are typically produced as slightly differing components of a particular chemical
family as a result of low specificity of some enzymes of secondary metabolism, and also of
bottleneck enzymes in the pathway, which lead to the excretion of pathway intermediates
and their transformed products. The ratio of components produced by a strain is often shifted
by the addition of a precursor of one of the components (‘directed biosynthesis’). The main
types of biosynthetic pathways involved are those forming peptides, polyketides, terpenoids,
oligosaccharides, aromatic compounds, and β-lactam rings. Unusual chemical structures
include β-lactam rings, cyclic peptides, depsipeptides containing ‘unnatural’ and nonprotein
amino acids, unusual sugars and nucleosides, unsaturated bonds of polyacetylenes and
polyenes, covalently bound chlorine and bromine; nitro-, nitroso-, nitrilo-, and isonitrilo
groups, hydroxamic acids, diazocompounds, phosphorus as cyclic triesters, phosphonic acids,
phosphinic acids, phosphoramides, 3-, 4-, and 7-membered rings and large rings such as the
37-membered ring system of macrolides, macrotetralides, and arisamycines.
The enormous diversity of secondary metabolites includes 23 000 terpenoids. At least 70
different deoxyhexose sugars are present in natural metabolites. Most of the secondary
metabolites are small (less than 1500 Da) and are produced by nonribosomal systems.
However, there does exist a family of ribosomally derived peptide antibiotics of higher
molecular weight (3000–4000 Da) known as bacteriocins or lantibiotics.
Despite the thousands of secondary metabolites made by microorganisms, they are
synthesized from only a few key precursors in pathways that comprise a relatively small
number of reactions and branch off from primary metabolism at a limited number of points.
Acetyl-coenzyme A (CoA) and propionyl-CoA are the most important precursors in secondary
metabolism, leading to polyketides, terpenes, steroids, and metabolites derived from fatty
acids. Other secondary metabolites are derived from intermediates of the shikimic acid
pathway, the tricarboxylic acid cycle, and from amino acids.
View chapter
Explore book
Aspergillus nidulans☆
B.R. Oakley, in Reference Module in Life Sciences, 2017
Secondary Metabolism
Secondary metabolites are compounds that are not required for the growth or reproduction
of an organism but are produced to confer a selective advantage to the organism. For
example, they may inhibit the growth of organisms with which they compete and, as such,
they often inhibit biologically important processes. Fungal secondary metabolites are a major
source of medically important compounds, from antibiotics such as penicillin to the anti-
cholesterol compound lovastatin. The sequencing of the genomes of A. nidulans and other
species of Aspergillus (Galagan et al., 2005) revealed that they have many genes predicted, on
the basis of sequence, to be involved in secondary metabolism. These genes, moreover, are
clustered together, and it has been demonstrated that individual clusters generally encode
the genes for a single secondary metabolite biosynthetic pathway. These secondary
metabolite biosynthetic clusters are potentially a very important source of medically useful
compounds, but most of the clusters are cryptic – not expressed under normal laboratory
growth conditions. Molecular genetic methods for activating secondary metabolite genes or
entire clusters are being developed, however. This has revealed new A. nidulans secondary
metabolites and is establishing A. nidulans as a model system for studying secondary
metabolism (Bok and Keller, 2004; Andersen et al., 2013; Brakhage, 2013; Chiang et al., 2013;
Yaegashi et al., 2014).
View chapter
Explore book
View chapter
Explore book
Secondary metabolites are low molecular weight compounds that have no recognized role
in the maintenance of fundamental life processes in the plants that synthesize them, but
have an important role in the interaction of the plant with its environment [5].
View chapter
Explore book
View chapter
Explore book
Animal Metabolites
K.-D. James, in Pharmacognosy, 2017
View chapter
Explore book
2. Media optimization
5. Elicitation
6. Precursor feeding
9. Dependent on type of explants (elite variety) and type of culture (organ, cell, callus, embryo, etc.)
10. Identification of genes and expression of encoding key enzymes for secondary metabolite synthesis
18. Biotransformation
Table 5.3. Some Reported Secondary Metabolites Produced by Plant Tissue Culture
Secondary Culture
hepatoprotective
human diseases
kinetin
fenestratum
americana
kinetin
rugosa
kinetin
buchanani kinetin
deltoidea
senticosus
peptic ulcer
sylvestre
stramonium
perforatum
vanadium
corylifolia
indicus
inflammatory
ledgeriana
serpentina
Resveratrol Vitis vinifera MS + IAA + GA3 + C Cardiac and anticancer effects [61]
UV
erythrorhizon kinetin
marianum
roseus
somnifera
S: Suspension; HR: Hairy root; C: Callus; Sc: Shoot culture; SL: Shootlet; ML: Multiple shoots
View chapter
Explore book
Fungal Metabolites
D.K. Daley, ... S. Badal, in Pharmacognosy, 2017
Lysergic acid diethyl amide, commonly known as LSD, is a member of the ergot alkaloids
and was accidentally discovered as a hallucinogen. Prior to its use as a recreational drug,
LSD was used in psychiatry to treat schizophrenia.
View chapter
Explore book
Abstract
Heterologous expression of fungal secondary metabolite genes allows for the product
formation of otherwise silent secondary metabolite biosynthesis pathways. It also allows
facile expression of mutants or combinations of genes not found in nature. This capability
makes model fungi an ideal platform for synthetic biology. In this chapter a detailed
description is provided of how to heterologously express any fungal secondary metabolite
gene(s) in a well-developed host strain of Aspergillus nidulans. It covers all the necessary
steps from identifying a gene(s) of interest to culturing mutant strains to produce secondary
metabolites.
View chapter
Explore book
Recommended publications
Phytochemistry
Journal
Tetrahedron
Journal
Journal of Biotechnology
Journal
Featured Authors
Verpoorte, Rob
Institute of Biology Leiden, Leiden, Netherlands
Proksch, Peter